Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.

Marko Lucijanic; Miran Lovrinov; Marko Skelin

首页> 外文期刊>Annals of Internal Medicine >Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.

【24h】

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.

机译：依赖于中间1风险骨髓增生综合征的输血依赖性患者的铁螯合。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Annals of Internal Medicine》 |2020年第7期|共1页
作者
Marko Lucijanic; Miran Lovrinov; Marko Skelin;
展开▼
作者单位

University Hospital Dubrava;

MakPharm;

General Hospital Sibenik;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes. [J] . Emanuele Angelucci, Peter Greenberg, Miguel Izquierdo, Annals of Internal Medicine . 2020,第7期

机译：依赖于中间1风险骨髓增生综合征的输血依赖性患者的铁螯合。
2. Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes. [J] . Marko Lucijanic, Miran Lovrinov, Marko Skelin Annals of Internal Medicine . 2020,第7期

机译：依赖于中间1风险骨髓增生综合征的输血依赖性患者的铁螯合。
3. Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes A Randomized Trial [J] . Angelucci Emanuele, Li Junmin, Greenberg Peter, Annals of Internal Medicine . 2020,第8期

机译：输血依赖性患者的铁螯合患者低至中间1 - 风险骨髓增强综合征A随机试验
4. Blood Compatible Macromolecular Chelators for Iron Chelation Therapy: An Innovative Approach To Treat Secondary Iron Overload [C] . Muhammad Imran ul-haq, Jasmine Hamilton, Benjamin Lai, World biomaterials congress . 2012

机译：血液相容性大分子螯合剂用于铁螯合疗法：治疗继发性铁超负荷的创新方法
5. Chronic Bone Marrow Failure and Transfusion Patterns: Epidemiological Studies of Blood Transfusions and Outcomes in Patients with Myelodysplastic Syndromes [D] . Rydén, Jenny. 2021

机译：慢性骨髓衰竭和输血模式：骨髓增生综合征患者出血和结果的流行病学研究
6. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study [O] . Aristoteles Giagounidis, Ghulam J Mufti, Moshe Mittelman, -1

机译：来那度胺治疗的独立缺失5q的低/中度1风险骨髓增生异常综合征的RBC输血依赖性患者的结果：MDS-004研究的子集分析
7. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: A subset analysis from the MDS-004 study [O] . Giagounidis, Aristoteles, Mufti, Ghulam, Mittelman, Moshe, 2014

机译：来那度胺治疗的独立缺失5q的低/中度-1风险性骨髓增生异常综合症的RBC输血依赖性患者的结果：MDS-004研究的子集分析

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.

著录项

引文网络

相似文献

相关主题

期刊订阅